Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Pathologie-Biologie|March 15, 2006
[Detection of nasal colonization methicillin-resistant Staphylococcus aureus: a prospective study comparing real-time genic amplification assay vs selective chromogenic media]J-C Nguyen Van, M-D Kitzis, A Ly, et al.
Presse Medicale (Paris, France : 1983)|May 3, 2002
[Treatment of severe botulism with 3,4-diaminopyridine]]M Dock, A Ben Ali, A Karras, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1983
[Suppurating splenic infarction originating from endocarditis]P Trunet, C Brun-Buisson, J Carlet, et al.
Annales De Chirurgie|January 1, 1991
[Improvement in the prognosis of severe mediastinitis by the use of muscle flaps]O Bical, C Le-Quang, J Carlet, et al.
Intensive Care Medicine|May 13, 2008
Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patientsC Cheval, J F Timsit, M Garrouste-Orgeas, et al.
The Journal of Rheumatology|July 1, 1997
Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patientsB Godeau, E Mortier, P M Roy, et al.
Presse Medicale (Paris, France : 1983)|July 4, 1992
[Isolated dissecting aneurysm of the superior mesenteric artery. Dysplasia, a rare cause of mesenteric ischemia. Report of a case]J Marzelle, F Gigou, F Cormier, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2003
Bacterial resistance to antibiotics in France : a public health priorityH Aubry Damon, J Carlet, P Courvalin, et al.
JAMA|September 27, 1995
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe SepsisC Brun-Buisson, F Doyon, J Carlet, et al.
Infection Control and Hospital Epidemiology|February 15, 2002
Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide useM Garrouste-Orgeas, J F Timsit, H Kallel, et al.
Pageof 10